Cost-Effectiveness of Sorafenib Versus Selective Internal Radiation Therapy for Patients with Advanced Hepatocellular Carcinoma

被引：0
|
作者：
Parikh, Neehar Dilip [1 ]
Singal, Amit G. [2 ]
Kulik, Laura M. [3 ]
Hutton, David [4 ]
机构：
[1] Univ Michigan, Internal Med, Ann Arbor, MI 48109 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Internal Med, Dallas, TX 75390 USA
[3] Northwestern Med Fac Fdn, Chicago, IL USA
[4] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
908
引用
收藏
页码：532A / 533A
页数：2
相关论文
共 50 条
  • [1] Cost-Effectiveness Analysis of Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres versus Sorafenib in Advanced Hepatocellular Carcinoma
    Marqueen, K. E.
    Ang, C.
    Mazumdar, M.
    Buckstein, M.
    Ferket, B. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E402 - E402
  • [2] Cost-effectiveness of sorafenib versus SBRT for unresectable advanced hepatocellular carcinoma
    Henry W. C. Leung
    Chung-Feng Liu
    Agnes L. F. Chan
    Radiation Oncology, 11
  • [3] The Cost-Effectiveness of Selective Internal Radiation Therapies Compared With Sorafenib for Treating Advanced Unresectable Hepatocellular Carcinoma in the United Kingdom
    Claxton, Lindsay
    Walton, Matthew
    Sharif-Hurst, Sahar
    Wade, Ros
    Eastwood, Alison
    Hodgson, Robert
    VALUE IN HEALTH, 2022, 25 (05) : 787 - 795
  • [4] Cost-effectiveness of sorafenib versus SBRT for unresectable advanced hepatocellular carcinoma
    Leung, Henry W. C.
    Liu, Chung-Feng
    Chan, Agnes L. F.
    RADIATION ONCOLOGY, 2016, 11
  • [5] Cost-Effectiveness Analysis of Selective Internal Radiotherapy With Yttrium-90 Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma
    Marqueen, Kathryn E.
    Kim, Edward
    Ang, Celina
    Mazumdar, Madhu
    Buckstein, Michael
    Ferket, Bart S.
    JCO ONCOLOGY PRACTICE, 2021, 17 (02) : E266 - E277
  • [6] Cost-effectiveness analysis of personalised versus standard dosimetry for selective internal radiation therapy with TheraSphere in patients with hepatocellular carcinoma
    Rognoni, Carla
    Barcellona, Maria Rosa
    Bargellini, Irene
    Bavetta, Maria Grazia
    Bello, Marilena
    Brunetto, Maurizia
    Carucci, Patrizia
    Cioni, Roberto
    Crocetti, Laura
    D'Amato, Fabio
    D'Amico, Mario
    Deagostini, Simona
    Deandreis, Desiree
    De Simone, Paolo
    Doriguzzi, Andrea
    Finessi, Monica
    Fonio, Paolo
    Grimaldi, Serena
    Ialuna, Salvatore
    Lagattuta, Fabio
    Masi, Gianluca
    Moreci, Antonio
    Scalisi, Daniele
    Virdone, Roberto
    Tarricone, Rosanna
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [7] THE COST-EFFECTIVENESS OF SELECTIVE INTERNAL RADIATION THERAPY (SIRT) FOR TREATING ADVANCED UNRESECTABLE HEPATOCELLULAR CARCINOMA IN THE UNITED KINGDOM
    Walton, M.
    Claxton, L.
    Sharif-Hurst, S.
    Wade, R.
    Eastwood, A.
    Hodgson, R.
    VALUE IN HEALTH, 2020, 23 : S406 - S406
  • [8] Nivolumab Versus Sorafenib as First-Line Therapy for Advanced Hepatocellular Carcinoma: A Cost-Effectiveness Analysis
    Li, Yan
    Liang, Xueyan
    Li, Huijuan
    Yang, Tong
    Guo, Sitong
    Chen, Xiaoyu
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [9] Nivolumab Versus Sorafenib as First-Line Therapy for Advanced Hepatocellular Carcinoma: A Cost-Effectiveness Analysis
    Li, Yan
    Liang, Xueyan
    Li, Huijuan
    Yang, Tong
    Guo, Sitong
    Chen, Xiaoyu
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [10] Cost-effectiveness of Sorafenib for Treatment of Advanced Hepatocellular Carcinoma in India
    Gupta, Nidhi
    Verma, Rohan K.
    Prinja, Shankar
    Dhiman, Radha K.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2019, 9 (04) : 468 - 475
12345